跳至主要内容
临床试验/JPRN-UMIN000029307
JPRN-UMIN000029307已完成未知

Efficacy and safety of pilocarpine / sodium alginate formulation for dry mouth in Sjogren's syndrome patients - Efficacy and safety of pilocarpine / sodium alginate formulation for dry mouth in Sjogren's syndrome patients

Teikyo University0 个研究点目标入组 50 人开始时间: 2017年9月27日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with ischemic heart disease 2. Patients with asthma or chronic obstructive airway disease 3. Patients with gastrointestinal obstruction or bladder neck obstruction 4. Patients with epilepsy 5. Patients with parkinsonism or Parkinson's disease 6. Patients with iritis 7. Patients with hypersensitivity on pilocarpine or arginine 8. Patients administered with pilocarpine hydrochloride within 6.5 hours 9. Patients administered with cevimeline hydrochloride hydrate within 20 hours 10. Patients administered with anetholtrithion within 9.5 hours 11. Patients judged by a physician to be inappropriate for inclusion in the study for any other reason

研究者

相似试验